Four Critical Factors for Clinical Trial Budget Success

Publications
Category:
Published on:
May 1, 2020
Written by:
Christopher Rao

Planning a relevant and accurate budget, regardless of the trial phase or indication, can be one of the most challenging aspects of the clinical trial process.

Though it is one of the most integral and essential components of the program, clinical trial budgets are often overly bulky, missing fine details or just plain inaccurate. This results in the need to re-forecast and re-plan, delay or even close a trial due to insufficient or improperly allocated funds.

How can you ensure your clinical trial budget is airtight? By taking a realistic approach to clinical trial budget planning and execution. Consider these four factors when developing your budget:

Chris Rao
  • Be realistic: Unrealistic timelines and cost ceilings are frequently pushed down from the top. Understand where you can shave time (and costs) off your trial plan and where it is simply not possible. A realistic view of costs, though sometimes painful, will help you plan for the necessities of the trial and will avoid “wishful thinking”. Examples of timelines which can only be minimally shifted are institutional startup timelines (such as IRB review) and regulatory timelines set by FDA or other agencies.
  • Understand your indication: Each indication is unique as it relates to subject accrual, institutional reimbursement and standard of care vs. protocol-required procedures. By having a firm grasp on the nuances of your patient population, you will be better equipped to estimate subject costs, institutional fees and enrollment rates at the site level, all of which have a direct budgetary impact.
  • Look for hidden costs: Sponsor companies are often plagued by “hidden” costs, such as clinical equipment rentals and unanticipated invoiceable study procedures at the site level, as well as study delays and other timeline changes which increase costs. Plan for the unexpected by building a cushion into your trial budget. Some sponsor companies will increase study-wide costs by a 5-10% margin, ensuring that an unanticipated delay or increased cost is not a budget-breaker.
  • Compare Service Providers: Not all service providers are created equally. When budgeting for items such as data management, clinical site monitoring and pharmacovigilance, your chosen service provider should be able to provide you with a clear, concise and understandable explanation of projected charges. While change orders are sometimes a necessary evil, a good service provider should ensure that these are the exception, rather than the norm.

Taking a practical and measured approach to clinical trial budgeting will help you build an initial trial budget that is as accurate as possible and provide some cushion to help weather unexpected storms that may pop up during your trial. With these factors in mind, you’ll be well on your way to success, without breaking the bank (or your budget).

Chris Rao is the Vice President, Clinical Development. Chris has over 15 years of experience in clinical research, with a focus on trial design and management.

For more information, please contact Christopher Rao.

For more information about Alira Health’s Clinical services

Click here

Related news

Clinical Regulatory
News January 7, 2021
Alira Health Adds CMC Services through Acquisition of Chamow & Associates
We have acquired Chamow & Associates (www.chamowassociates.com), a California-based integrated CMC advisory firm. This acquisition brings expertise in biologics manufacturing, quality(...)
Clinical
Publications September 4, 2020
Clinical Trial Management – The Dharmic Approach
In this article, Sheryl Kelley, Alira Health’s Associate Director of Data Quality and Finance (and certified yoga instructor), writes about the connections between yoga, dharma, and(...)
Clinical
Publications July 1, 2020
Clinical Trials Trends: Remote Monitoring
The COVID-19 pandemic caused an urgent need to transition clinical trials from on-site to remote monitoring. Though the concept of remote monitoring existed before the pandemic, with(...)
Clinical
Publications May 6, 2020
What You Should Know before Selecting a CRO
When running a clinical trial, it is important to choose the right CRO. This choice impacts the quality and experience of conducting the study.
Clinical
Publications May 1, 2020
Clinical Trial Guidance for Sponsors: Four Critical Steps for Clinical Trial Success
As many seasoned clinical trial sponsors know, there are several factors that affect the outcome of a trial. While some of these factors are out of their control, there are a few fundamental(...)
Clinical
Multimedia April 8, 2020
Chris Rao Discusses the Impact of COVID-19 on Clinical Trials
Watch a replay of our recent webinar on the Impact Of COVID-19 On Clinical Trials. Clinical trials have been heavily impacted by the COVID-19 crisis, affecting companies in all stages of development.
Clinical
Multimedia April 5, 2020
Alira Health Webinar | COVID-19 Supply Shortage: Causes, Impact, and Solutions
Replay of our recent webinar on the COVID-19 Supply Shortage: Causes, Impact, and Solutions.

Our locations around the globe

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.